NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML-Reference-Cited by-同舟云学术

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

Published:2017-03-24 Issue:12 Volume:6 Page:e1307491
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Chretien Anne-Sophie¹²,Devillier Raynier¹³,Fauriat Cyril¹²,Orlanducci Florence²,Harbi Samia³,Le Roy Aude¹²,Rey Jérôme³,Bouvier Borg Gaelle⁴,Gautherot Emmanuel⁴,Hamel Jean-François⁴,Ifrah Norbert⁵,Lacombe Catherine⁶^ORCID,Cornillet-Lefebvre Pascale⁷,Delaunay Jacques⁸,Toubert Antoine⁹,Arnoulet Christine¹¹⁰,Vey Norbert¹³,Blaise Didier¹³,Olive Daniel¹²

Affiliation:

1. Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068; CNRS, UMR7258, Institut Paoli-Calmettes; Aix-Marseille University, UM 105, Marseille, France

2. Immunomonitoring platform, Institut Paoli-Calmettes, Marseille, France

3. Hematology Department, Institut Paoli-Calmettes, Marseille, France

4. Beckman Coulter Immunotech, Biostatistics and methodology department, CHU Angers, Angers, France

5. Hematology department, CHU Angers, Angers, France

6. GOELAMStheque, FILO (French Innovative Leukemia Organization), Cochin Hospital, APHP, Paris, FRANCE

7. Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Reims, France

8. Service d'Hématologie, Centre Catherine de Sienne, Nantes, France

9. INSERM UMRS-1160, Univ Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Immunology and Histocompatibility department, Hôpital Saint-Louis, APHP, Paris, France

10. Biopathology Department, Institut Paoli Calmettes, Marseille, France

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1307491

Reference45 articles.

1. Acute Myeloid Leukemia

2. Bring on the biomarkers

3. Biomarkers and surrogate end points—the challenge of statistical validation

4. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

5. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Killer cells at the frontline in the fight against cancer;Cell Death & Disease;2024-08-23

2. Unveiling mitochondrial and ribosomal gene deregulation and tumor microenvironment dynamics in acute myeloid leukemia;Cancer Gene Therapy;2024-05-28

3. Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET® CC-96191;Cancers;2024-02-22

4. Inhibitory receptors and checkpoints on NK cells: Implications for cancer immunotherapy;Pathology - Research and Practice;2024-01

5. Functional features of natural killer cells in acute myeloid leukemia;Oncohematology;2023-12-08